DOI: 10.2337/diaclin.26.1.29 © 2008 by the American Diabetes Association
The Florida Diabetes Master Clinician Program: Facilitating Increased Quality and Significant Cost Savings for Diabetic Patients
Up to 10% of Americans > 20 years of age have type 2 diabetes, and > 20% have the metabolic syndrome.1,2 The prevalence of both has increased by 33% during the past decade as a result of an increasingly sedentary lifestyle, the epidemic of obesity, the growth of ethnic groups at risk for the disease, and the aging of the population. The prevalence of the metabolic syndrome increases dramatically with age, and 45% of people > 60 years of age have the syndrome. Type 2 diabetes will develop in many of these individuals.1,2
In the United States, diabetes is the sixth leading cause of death; the
leading cause of renal failure (end-stage renal disease), nontraumatic limb
amputations, and blindness; and the leading contributor to cardiovascular
disease (CVD). CVD accounts for
Despite our increased knowledge and understanding of the pathophysiology
and management of diabetes, patient outcomes have not shown a parallel
improvement. A large gap exists between our knowledge and our
performance.7,8
Based on excellent evidence, the American Diabetes Association (ADA) has set
the following goals: hemoglobin A1c (A1C)
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||